Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Chemmedchem|November 24, 2015
Identification of HDAC6-Selective Inhibitors of Low Cancer Cell CytotoxicityIrina N Gaisina, Werner Tueckmantel, Andrey Ugolkov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2017
Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of CancerAmy Walz, Andrey Ugolkov, Sunandana Chandra, et al.
Frontiers in Immunology|March 9, 2023
VISTA expression and patient selection for immune-based anticancer therapyAlexander S Martin, Michael Molloy, Andrey Ugolkov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
Whole-body Imaging of Cell Death Provides a Systemic, Minimally Invasive, Dynamic, and Near-real Time Indicator for Chemotherapeutic Drug ToxicitySteven E Johnson, Andrey Ugolkov, Chad R Haney, et al.
Translational Oncology|July 4, 2017
Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft ModelsAndrey Ugolkov, Wenan Qiang, Gennadiy Bondarenko, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 3, 2014
Biodistribution and in vivo toxicity of aptamer-loaded gold nanostarsDuncan Hieu M Dam, Kayla S B Culver, Irawati Kandela, et al.
Cancer Letters|July 18, 2016
GSK-3 inhibition overcomes chemoresistance in human breast cancerAndrey Ugolkov, Irina Gaisina, Jin-San Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2025
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland CarcinomaGlenn J Hanna, Nicole Scarfo, Kee-Young Shin, et al.
Plos One|January 28, 2014
Identification of a new epitope in uPAR as a target for the cancer therapeutic monoclonal antibody ATN-658, a structural homolog of the uPAR binding integrin CD11b (αM)Xiang Xu, Yuan Cai, Ying Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2019
Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to Chemotherapy by Abrogating the TopBP1/ATR-Mediated DNA Damage ResponseLi Ding, Vijay S Madamsetty, Spencer Kiers, et al.
Pageof 3